Xtant Medical Holdings, Inc.
XTNT · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $33,255 | $35,411 | $32,904 | $31,513 |
| % Growth | -6.1% | 7.6% | 4.4% | – |
| Cost of Goods Sold | $11,263 | $11,127 | $12,661 | $15,489 |
| Gross Profit | $21,992 | $24,284 | $20,243 | $16,024 |
| % Margin | 66.1% | 68.6% | 61.5% | 50.8% |
| R&D Expenses | $634 | $566 | $443 | $522 |
| G&A Expenses | $7,071 | $7,478 | $7,533 | $5,700 |
| SG&A Expenses | $18,817 | $19,094 | $18,737 | $17,384 |
| Sales & Mktg Exp. | $11,746 | $11,616 | $11,204 | $11,684 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19,451 | $19,660 | $19,180 | $17,906 |
| Operating Income | $2,541 | $4,624 | $1,063 | -$1,882 |
| % Margin | 7.6% | 13.1% | 3.2% | -6% |
| Other Income/Exp. Net | -$976 | -$819 | -$1,030 | -$1,262 |
| Pre-Tax Income | $1,565 | $3,805 | $33 | -$3,144 |
| Tax Expense | $257 | $255 | -$25 | $21 |
| Net Income | $1,308 | $3,550 | $58 | -$3,165 |
| % Margin | 3.9% | 10% | 0.2% | -10% |
| EPS | 0.009 | 0.026 | 0 | -0.023 |
| % Growth | -63.1% | 6,275% | 101.8% | – |
| EPS Diluted | 0.009 | 0.024 | 0 | -0.023 |
| Weighted Avg Shares Out | 139,311 | 139,311 | 143,564 | 138,978 |
| Weighted Avg Shares Out Dil | 148,574 | 148,574 | 143,335 | 138,978 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $904 | $1,004 | $1,045 | $1,134 |
| Depreciation & Amortization | $1,161 | $1,169 | $1,074 | $1,148 |
| EBITDA | $3,630 | $5,978 | $2,152 | -$862 |
| % Margin | 10.9% | 16.9% | 6.5% | -2.7% |